Vanguard Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.29B | Buy |
|
|||||
|
2022
Q2 | $1.23B | Buy |
|
|||||
|
2022
Q1 | $1.63B | Buy |
|
|||||
|
2021
Q4 | $1.74B | Buy |
|
|||||
|
2021
Q3 | $1.56B | Sell |
|
|||||
|
2021
Q2 | $1.52B | Buy |
|
|||||
|
2021
Q1 | $1.53B | Buy |
|
|||||
|
2020
Q4 | $1.56B | Sell |
|
|||||
|
2020
Q3 | $1.34B | Buy |
|
|||||
|
2020
Q2 | $1.16B | Sell |
|
|||||
|
2020
Q1 | $711M | Buy |
|
|||||
|
2019
Q4 | $817M | Buy |
|
|||||
|
2019
Q3 | $850M | Buy |
|
|||||
|
2019
Q2 | $1.22B | Sell |
|
|||||
|
2019
Q1 | $1.39B | Sell |
|
|||||
|
2018
Q4 | $1.64B | Buy |
|
|||||
|
2018
Q3 | $2.09B | Buy |
|
|||||
|
2018
Q2 | $1.79B | Buy |
|
|||||
|
2018
Q1 | $1.04B | Buy |
|
|||||
|
2017
Q4 | $654M | Buy |
|
|||||
|
2017
Q3 | $576M | Buy |
|
|||||
|
2017
Q2 | $475M | Buy |
|
|||||
|
2017
Q1 | $409M | Sell |
|
|||||
|
2016
Q4 | $374M | Buy |
|
|||||
|
2016
Q3 | $400M | Buy |
|
|||||
|
2016
Q2 | $304M | Sell |
|
|||||
|
2016
Q1 | $266M | Sell |
|
|||||
|
2015
Q4 | $276M | Sell |
|
|||||
|
2015
Q3 | $311M | Buy |
|
|||||
|
2015
Q2 | $210M | Buy |
|
|||||
|
2015
Q1 | $212M | Buy |
|
|||||
|
2014
Q4 | $95.5M | Buy |
|
|||||
|
2014
Q3 | $61.1M | Buy |
|
|||||
|
2014
Q2 | $60.9M | Buy |
|
|||||
|
2014
Q1 | $62.9M | Buy |
|
|||||
|
2013
Q4 | $59.8M | Buy |
|
|||||
|
2013
Q3 | $41.5M | Sell |
|
|||||
|
2013
Q2 | $49.9M | Buy |
|